in a pilot study the therapeutic effect of 2 x 500 mg etofibrate ( lipo merz retard ) on lipids and lipoproteins , fibrinolytic activity and clinical parameters was studied for four weeks in hyperlipidemic patients suffering from arteriosclerosis obliterans ( fontaine stage ii/iii ) .
C0023779
lipids
C0023820
lipoproteins